Infectious Disease
Researchers protecting
health and prosperity
It’s the fifth anniversary of the COVID-19 pandemic and McMaster researchers are developing a better vaccine, using AI to power drug discovery, and sharing evidence-based ways to protect the health of communities and the economy.
McMaster’s inhaled COVID-19 vaccine advances to next phase
While the current, needle-based COVID-19 vaccines have prevented a tremendous amount of death and hospitalization, they haven’t really changed a lot of people’s experience with getting recurrent infections. So, we’re looking to change that by providing robust protection directly at the site of infection.
Professor Fiona Smaill, Department of Pathology & Molecular Medicine.
Information Box Group
“We are only safe if everyone is safe.”
At first glance, biomedical science and cultural studies couldn’t be more different. But they’re two sides of the same coin when it comes to keeping communities safe and healthy, experts say.
Matthew Miller, an associate professor in the department of Biochemistry and Biomedical Sciences; and Chandrima Chakraborty, a professor in the department of English & Cultural Studies, say bioscience generates critical health innovations, and cultural experts help ensure those innovations are better trusted, accepted and used by society.
Miller and Chakraborty sat down to discuss how Global Nexus is fostering collaborative work to bring new health products to market while also addressing gaps in efficiency, access and equity.
Drug discovery and biomanufacturing hub
Meet our experts
Want to learn more?
Sign up to receive future communications from McMaster University
